Fera Pharmaceuticals is pleased to announce that it has been selected by Pragma Pharmaceuticals to launch Amoxicillin Extended-Release Tablets, the authorized generic for Moxatag.
Craig Salmon, VP of Sales at Fera talking with Surgical Blog said, “By having an authorized generic available, it is our hope that more patients will gain access to this once-a-day antibiotic therapy helping to ensure greater adherence and compliance.”
About Fera Pharmaceuticals, LLC
Fera Pharmaceuticals is a privately held company. The company goal is to realize opportunities via acquisitions, in-licensing, developing and marketing abbreviated new drug applications (ANDAs), new drug applications (NDAs) and 505(b)(2) NDA products. Areas of interest include products that could benefit from lifecycle management with a special focus on niche markets.